Add To Watchlist

BIOTECH

→ Show Results From: All | Technology | Business
The Wire

Merck buys British maker of biotech medicines

Merck & Co. said Thursday it is making another deal in its strategy to become a top maker of biotech drugs, buying a British company that makes them.

Deal with South Korean firm brings jobs to Vermont

Gov. Jim Douglas' office says his trip to Asia is paying off, with an agreement with a Korean firm that's expected to bring more than 200 jobs to northern Vermont's Orleans County.

Biogen Idec extends bid for Facet Biotech

Biotech drugmaker Biogen Idec said Friday it has extended its tender offer for shares of Facet Biotech Corp., after the company's board unanimously rejected the hostile takeover bid.

Calif. biotech exec convicted of marketing fraud

The former chief executive of the biotechnology company InterMune Inc. has been convicted of wire fraud in marketing of the drug Actimmune.

Education linked to biotechnology expansion

South Dakota must overcome what university president James Abbott characterized as an inferiority complex if it's to produce college graduates who can grow a biotechnology industry that's already taken root.

THE INFLUENCE GAME: Biotech drug lobbying war

With the nation's $46 billion biological drug market at stake, the war between makers of the pricey biotech medicines and their would-be generic competitors has involved millions of dollars in lobbying, thousands in campaign contributions and uncounted visits to members of Congress. And one noteworthy letter.

Cardinal Health buys imaging company Biotech

Cardinal Health Inc. said Monday it agreed to buy radiologic imaging company Biotech for an undisclosed amount.

FTC pans biotech demands for generic competition

The biotechnology industry's demand for up to 14 years of competition-free marketing before cheaper copies of their drugs can be launched is unnecessary and would discourage development of new treatments, the Federal Trade Commission told lawmakers Thursday.

Top Democrat pushes for action on biotech drugs

As the Obama administration renews its health care reform effort on Capitol Hill, a top Democrat is calling for speedy action on a yearslong effort to create generic competition for costly biotech drugs.

Report: Financial Crisis could reshape biotech

The U.S. biotech industry became profitable as a whole for the first time in 2008, a new report says, but the global financial crisis has led to a pullback in the investment that drives the industry's expensive research.

Generic biotech effort picks up steam in Congress

Biotech drugs that now cost thousands of dollars per month would have to compete with lower-cost generic versions after just five years on the market, under a new congressional proposal.

Lawmakers introduce biogenerics bill

A bipartisan group in Congress wants to give the Food and Drug Administration power to approve copies of costly biotech drugs.

Experimental cotton unlikely to pose feed hazard

An unauthorized strain of genetically modified cotton was accidentally mixed in with other harvested cotton in Texas last month, but government officials on Wednesday played down any safety concerns.

Safety a problem for new generation drugs, too

Nearly a fourth of widely used new-generation biological drugs for several common diseases produce serious side effects that lead to safety warnings soon after they go on the market, the first major study of its kind found.

Biotech corn, soybeans encroaching on wheat acres

Biotechnology that allows more profitable corn and soybean crops to thrive in arid fields is encroaching on traditional wheat acreage across the Great Plains, industry experts say.

EU urged to reject 3 new biotech crops

Environmental groups appealed to the European Union on Monday to reject applications from the biotech industry to approve one newly engineered potato variety and two corn crops.

Court cuts $200M from royalty judgment against Genentech

The California Supreme Court has slashed $200 million from a judgment against Genentech Inc.

Biotech Co.'s Ex-CEO Charged With Fraud

The former chief executive of the biotechnology company InterMune Inc. was charged in federal court Tuesday with orchestrating an illegal marketing scheme of the drug Actimmune.

France Halts Genetically Modified Corn

The French government on Saturday suspended the use of genetically modified corn crops in France while it awaits EU approval for a full ban.

Report: Calif. Biotech Up but Uncertain

California's biotechnology industry is growing steadily, but the looming possibility of increased government oversight could stifle new drug development, according to an industry-supported report set for release Thursday.

Drug Firms Cool to Stem Cell Findings

Despite excitement among some scientists — and at the White House — about an embryo-free technique for creating human stem cells, reaction from companies that might turn the research into treatments was muted.

Activist, Guard Killed on Brazil Biofarm

Two people were shot dead when activists were confronted by armed men as they invaded a Swiss-owned farm that has been a flashpoint in the debate over biotech crops, authorities and the company said Monday.

Does Less Trans Fat Make Food Healthier?

A major change in the national diet is under way: Heart-damaging trans fat is rapidly disappearing from grocery aisles and restaurant food, too. But are its replacements really healthier?

U.S. Sees No Breakthrough at WTO Talks

The United States downplayed prospects for an immediate breakthrough in stalled global trade negotiations as top officials from six member nations of the World Trade Organization headed Thursday for talks in India.

Bush to Meet With New Mexican President

Mexican President Felipe Calderon has a tough message for President Bush: The United States must do more — "much more" — to solve thorny issues of drug-trafficking and immigration. At the last stop on his Latin American tour, Bush must convince Calderon on Tuesday that he's committed to soothing strained U.S.-Mexico relations, which only got worse when Bush signed a law calling for construction of more than 700 miles of new fencing along the long border the two countries share.

The Vine
Three Major GMOs Approved for Food and Feed Found Unsafe
Source: International Journal of Biological Sciences

There is a world-wide debate concerning the safety and regulatory approval process of genetically modified (GM) crops and foods [1, 2].

Who owns the dead zone?
Source: Rodale Institute

Agricultural pollution flowing out of the Midwest kills aquatic life in the Gulf of Mexico, with seafood harvesters and eaters paying the cost for this displaced cost of "cheap food." By Krista Hozyash

The Organic Center :: State of Science :: Pesticides
Source: organic-center.org

A new study by the Organic Center shows GMO crop acres require over 26% more pounds of pesticides per acre than acres planted to conventional varieties, debunking biotech claims that GMOs decrease pesticide use.

Monsanto and the Round Table on Responsible Soy (RTRS)
Source: Angry Mermaid

Nominated for lobbying for RoundupReady (RR) soy to be considered a "climate-friendly" crop that is eligible for carbon credits and subsidies under the Clean Development Mechanism (CDM); and for pushing for meaningless 'responsible' label for RoundupReady soy, which could be used …

NYT: 22 Republicans, 20 Democrats Used Lobbying Firm's Statements In House Health Care Speeches
Source: The New York Times

In the official record of the historic House debate on overhauling health care, the speeches of many lawmakers echo with similarities. Often, that was no accident.

Sanofi-Aventis wants to 'play nice' with smaller and nimbler biotechs in Boston
Source: The Boston Globe

The drug company, which has about 98,000 employees worldwide and rang up sales of $37 billion in 2008, has focused its core business in the fields of oncology, immunology, and inflammation.

Industry avoid the truth about GM segregation problems
Source: Network of Concerned Farmers

As farmers are commencing delivery of their canola, the agricultural industry is avoiding answering genuine questions from non-GM farmers who claim need answering prior to delivery.

Corporate investors lead the rush for control over overseas farmland
Source: GRAIN

With all the talk about "food security," and distorted media statements like "South Korea leases half of Madagascar's land,"1 it may not be evident to a lot of people that the lead actors in today's global land grab for overseas food production are not countries or governments  …

Can Biotech Food Cure World Hunger?
Source: The New York Times

With food prices remaining high in developing countries, the United Nations estimates that the number of hungry people around the world could increase by 100 million in 2009 and pass the one billion mark.

Bleeding Biotech
Source: American.com

Across the continent, Congress is also thinking about biotech.

Monsanto Under Investigation For Antitrust Abuses
Source: npr

The Justice Department is investigating whether Monsanto Co. violated antitrust rules in trying to expand its dominance of the market for genetically engineered crops.

Obama Caves to Agribusiness
Source: CoOp America

by Kathy Ozer and Marcia Ishii-Eiteman "Lobbyists won't find a job in my White House." President Obama assured us with this claim upon inauguration.

Angry Thai farmers call for ban on GM rice
Source: Third World Network

Mae-Wan Ho reports on an extraordinary gathering of Thai farmers, activists, government officials, academics and rice research scientists with the objective of securing official protection for indigenous biodiversity knowledge and wisdom.

FDA Needs To Dismiss Former Monsanto Counsel
Source: The Huffington Post

The recent appointment of Michael Taylor as FDA's Senior Food Safety Advisor is of major public health concern.

Spiration lands funding to continue emphysema trials
Source: Tech Flash

TechFlash looks at Spriation's latest funding round, providing insight into the company's product.

Monsanto's GMO sugar beets 95% of America's 1.16 million total acres
Source: Capital Press AgWeek

Without human health studies or environmental impacts debated, Monsanto has taken America's sugar beet crop for it's own fee based seed and chemical portfolio.

Obama's Chief Agricultural Negotiator Nominee a Pesticide Pusher
Source: The Huffington Post

The industrial agriculture complex has been doing back flips for the last few weeks, first because of the ascendancy of Blanche Lincoln (ConservaDem-AR) to the high throne of the Senate Agriculture Committee, where she promises to pinch climate legislation (or at the very least s …

Federal Court rejects genetically modified sugar beets
Source: The San Francisco Chronicle

The government illegally approved a genetically modified, herbicide-resistant strain of sugar beets without adequately considering the chance they will contaminate other beet crops, a federal judge in San Francisco has ruled.

US Export Losses Mount - EU rejects more U.S. soy with GM corn traces
Source: Reuters

AMSTERDAM/BRUSSELS Sept 18 (Reuters) - Spanish authorities detected traces of unauthorised forms of genetically modified (GM) corn in U.S. soy shipments on August 25 and blocked the imports, a European Commission spokeswoman said on Friday.

Japan set to reject genetically engineered canola
Source: True Food Network

Australia's canola exports are likely to be significantly impacted by the change of government in Japan.

Why I Still Oppose Genetically Modified Crops
Source: Yale Environment 360

Note - Verlyn Klinkenborg is a member of the editorial board at the New York Times

Why GMO Foods Have Failed at Producing Healthy Food for More People
Source: TreeHugger

For a technology that has sucked up billions of research dollars and prolonged agriculture's dependence on chemical inputs, GMOs (genetically modified organisms) have yet to justify their role in a world desperate for more sustainable ways to produce healthier food for more peopl …

Bill Gates Strategy for Ending Africa's Hunger With Fee Based Seed
Source: The Nation

The architects of Africa's new Green Revolution at the Gates Foundation are sensitive to these flaws.

When Cocaine and Monsanto's Roundup Collide, War on Drugs Becomes a Genetically-Modified War on Science
Source: BuzzFlash.org - Progressive News and Commentary with an Attitude | Fight Ignorance: Read BuzzFlash

At the intersection of cocaine and Roundup in rural South America, Monsanto and the U.S. government are struggling to keep up appearances. That's becoming more and more difficult as the unanticipated hazards of genetic modification become clearer.

Kowtowing to Monsanto still leaves a nasty aftertaste
Source: Guardian Unlimited

Catherine Bennett The Observer, Sunday 16 August 2009 Article history Eat GM: "Better than starving to death!" It is not the most persuasive slogan in the history of food advertising.

This area needs news. Click here to seed the vine